Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

PositiveID Partners International Maritime Medical Association

PositiveID has partnered with the International Maritime Medical Association (IMMA) to offer Health Link personal health record (PHR) to approximately one and a half million seafarers per year on a paid subscription basis.

PositiveID said that it is expected to launch the partnership with a pilot program for up to 1,000 seafarers in Antwerp, Belgium and Manila, Philippines. Upon successful completion and review of the pilot program, PositiveID will offer its Health Link Person Health Record (PHR) to millions of seafarers and port workers per year, on a paid subscription basis.

Health Link is an electronic, web-based PHR that enables a patient to manage personal medical information and history from anywhere there is an internet connection. Health Link, engineered to be interoperable with Microsoft HealthVault, Google Health and various electronic medical records systems, connects patients to personalized health education and provides online connectivity to caregivers and physicians.

PositiveID also said that through reminders and alerts that can be tailored to suit an individual’s circumstances, users are reminded of important actions and receive suggestions to better manage their health. This includes everything from refilling prescriptions on time, appointment reminders, drug interaction warnings, and tips for preventative actions.

Scott Silverman, chairman and CEO of PositiveID, said: “We believe this partnership with IMMA is a perfect example of how patient care can be improved and healthcare costs decreased using our Health Link PHR. By providing patients and physicians with access to health data anytime, anywhere, we can overcome many of the inefficiencies of healthcare today while maintaining patient privacy. We believe this relationship holds significant promise, both from a patient and financial perspective.”